Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02322762
Other study ID # D1690R00002
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 30, 2014
Est. completion date August 21, 2019

Study information

Verified date June 2022
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

DISCOVER is a Non Interventional Study study to describe the disease management patterns and clinical evolution over three years in type 2 diabetes mellitus patients initiating a second line anti-diabetic treatment.


Description:

DISCOVER is a NIS study to describe the disease management patterns and clinical evolution over three years in type 2 diabetes mellitus patients initiating a second line anti-diabetic treatment. This study is a multi-country, multicenter, observational, prospective, longitudinal cohort study. The patients will be recruitted from countries in Latin America, Europe and Asia pac. It is estimated that approximately 13350 patients will be enrolled in total with each patient followed up for 3 years.


Recruitment information / eligibility

Status Completed
Enrollment 15992
Est. completion date August 21, 2019
Est. primary completion date August 21, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Provision of subject informed consent 2. Female or male aged 18 years and over 3. Diagnosed with type 2 diabetes mellitus 4. Initiating a second line anti-diabetic therapy, either as add-on, or switching from one monotherapy to another. Exclusion Criteria: 1. Diagnosis of type 1 diabetes mellitus 2. Patient is pregnant 3. Patients initiating a dual therapy after having previously received two different lines of monotherapy before (e.g.: Metformin ? SU (Sulphonylureas) ? SU+Add-on) 4. Current treatment with chemotherapy, oral or iv steroids 5. Patient is on dialysis or has had a renal transplant 6. The patient is taking insulin as first line treatment 7. The patient is taking dual therapy or a fixed dose combination treatment as first line treatment. 8. The patient is taking herbal remedies / natural medicines as first line treatment 9. Participation in an interventional trial 10. Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient for 3 years (e.g. lifethreatening co-morbidities, tourist, non-native speaker or does not understand the local language where interpreter services are not reliably available, psychiatric disturbances, dementia, alcohol or drug abuse). 11. Not willing to sign the informed consent.

Study Design


Locations

Country Name City State
Algeria Research Site Alger
Algeria Research Site Algiers
Algeria Research Site Batna
Algeria Research Site Blida
Algeria Research Site Constantine
Algeria Research Site Oran
Algeria Research Site Setif
Argentina Research Site Chacabuco
Argentina Research Site Ciudad Autonoma Buenos Aires
Argentina Research Site Ciudad Autonoma de Buenos Aires
Argentina Research Site Cordoba
Argentina Research Site Corrientes
Argentina Research Site Parana
Argentina Research Site Rosario
Argentina Research Site San Miguel de Tucuman
Argentina Research Site Santa Fe
Australia Research Site Blacktown
Australia Research Site Burwood
Australia Research Site Castle Hill
Australia Research Site Coorparoo
Australia Research Site Corio
Australia Research Site Cowra
Australia Research Site Edmonton
Australia Research Site Forbes
Australia Research Site Garran
Australia Research Site Ipswich
Australia Research Site Melbourne
Australia Research Site Sherwood
Australia Research Site Smithfield
Australia Research Site South Lake
Austria Research Site Feldbach
Austria Research Site Graz
Austria Research Site Innsbruck
Austria Research Site Linz
Austria Research Site Salzburg
Austria Research Site St.Veit im Pongau
Austria Research Site Stankt Stefan Ob Stainz
Austria Research Site Vienna
Austria Research Site Wien
Bahrain Research Site Bahrain
Brazil Research Site Belo Horizonte
Brazil Research Site Brasilia
Brazil Research Site Campina Grande do Sul
Brazil Research Site Campinas
Brazil Research Site Curitiba
Brazil Research Site Fortaleza
Brazil Research Site Juiz de Fora
Brazil Research Site Porto Alegre
Brazil Research Site Rio de Janeiro
Brazil Research Site Santa Maria
Brazil Research Site Sao Jose do Rio Preto
Brazil Research Site Sao Jose dos Campos
Brazil Research Site Sao Paulo
China Research Site Beijing
China Research Site Changsha
China Research Site Chengdu
China Research Site Chenzhou
China Research Site Chongqing
China Research Site Fuzhou
China Research Site Guangzhou
China Research Site Guiyang
China Research Site Hefei
China Research Site Kunming
China Research Site Lanzhou
China Research Site Nanjing
China Research Site Panjin
China Research Site Shanghai
China Research Site Shantou
China Research Site Shijiazhuang
China Research Site Shiyan
China Research Site Suzhou City
China Research Site Tianjin
China Research Site Urumchi
China Research Site Wuhan
China Research Site Wuxi
Colombia Research Site Barranquilla
Colombia Research Site Bogota
Colombia Research Site Cali
Colombia Research Site Manizales
Colombia Research Site Medellin
Costa Rica Research Site Cartago
Costa Rica Research Site Heredia
Costa Rica Research Site San Jose
Czechia Research Site Benatky nad Jizerou
Czechia Research Site Beroun
Czechia Research Site Broumov
Czechia Research Site Dolni Brezany
Czechia Research Site Karlovy Vary
Czechia Research Site Krnov
Czechia Research Site Litomerice
Czechia Research Site Nachod
Czechia Research Site Olomouc
Czechia Research Site Ostrava
Czechia Research Site Plzen
Czechia Research Site Praha
Czechia Research Site Uherske Hradiste
Czechia Research Site Ujezd U Brna
Egypt Research Site Alexandria
Egypt Research Site Asyut
Egypt Research Site Cairo
Egypt Research Site Giza
Egypt Research Site Heliopolis
Egypt Research Site Mansoura
Egypt Research Site Minya
Egypt Research Site Tanta
India Research Site Bangalore
India Research Site Chandigarh
India Research Site Chennai
India Research Site Coimbatore
India Research Site Delhi
India Research Site Ghaziabad
India Research Site Gurgaon
India Research Site Hyderabad
India Research Site Indore
India Research Site Jaipur
India Research Site Kanpur
India Research Site Karnal
India Research Site Kolkata
India Research Site Mangalore
India Research Site Mumbai
India Research Site Nagpur
India Research Site Noida
India Research Site Pune
India Research Site Trivandrum
Indonesia Research Site Balikpapan
Indonesia Research Site Banda Aceh
Indonesia Research Site Batu
Indonesia Research Site Bekasi Timur
Indonesia Research Site Denpasar
Indonesia Research Site Jakarta
Indonesia Research Site Malang
Indonesia Research Site Manado
Indonesia Research Site Padang
Italy Research Site Foggia
Italy Research Site Garbagnate Milanese
Italy Research Site Livorno
Italy Research Site Mariano Comense
Italy Research Site Parma
Italy Research Site Pavia
Italy Research Site Pisa
Italy Research Site Potenza
Italy Research Site Rimini
Italy Research Site Roma
Italy Research Site Sesto San Giovanni
Jordan Research Site Amman
Jordan Research Site Az Zarqaa
Jordan Research Site Irbid
Korea, Republic of Research Site Bucheon-si
Korea, Republic of Research Site Cheonan-si
Korea, Republic of Research Site Chuncheon-si
Korea, Republic of Research Site Daejeon
Korea, Republic of Research Site Goyang-si
Korea, Republic of Research Site Gwangmyeong Si
Korea, Republic of Research Site Iksan
Korea, Republic of Research Site Jeju Special Self-Governing Province
Korea, Republic of Research Site Seongnam-si
Korea, Republic of Research Site Seoul
Kuwait Research Site Kuwait City
Lebanon Research Site Beirut
Lebanon Research Site Chtoura
Lebanon Research Site Hamra
Lebanon Research Site Jbeil
Lebanon Research Site Mazraat Yachouh
Lebanon Research Site Saida
Lebanon Research Site Tripoli
Lebanon Research Site Tyre
Malaysia Research Site Air Itam
Malaysia Research Site Alor Setar
Malaysia Research Site Ipoh
Malaysia Research Site Johor Bahru
Malaysia Research Site Kelantan
Malaysia Research Site Kuala Krai
Malaysia Research Site Masjid Tanah
Malaysia Research Site Miri
Malaysia Research Site Perak
Malaysia Research Site Sandakan
Malaysia Research Site Seremban
Mexico Research Site Acapulco de Juarez
Mexico Research Site Aguascalientes
Mexico Research Site Chihuahua
Mexico Research Site Guadalajara
Mexico Research Site Mexico
Mexico Research Site Monterrey
Mexico Research Site San Juan del Rio
Mexico Research Site Tamaulipas
Mexico Research Site Zapopan
Netherlands Research Site Almelo
Netherlands Research Site Alpen Aan Den Rijn
Netherlands Research Site Amersfoort
Netherlands Research Site Amsterdam
Netherlands Research Site De Bilt
Netherlands Research Site Den Haag
Netherlands Research Site Doetinchem
Netherlands Research Site Dordrecht
Netherlands Research Site Dorst
Netherlands Research Site Elst
Netherlands Research Site Enschede
Netherlands Research Site Etten-Leur
Netherlands Research Site Garderen
Netherlands Research Site Geleen
Netherlands Research Site Gouda
Netherlands Research Site Hoogezand
Netherlands Research Site Katwijk
Netherlands Research Site Kerkrade
Netherlands Research Site Kloosterhaar
Netherlands Research Site Landgraaf
Netherlands Research Site Luttenberg
Netherlands Research Site Nijverdal
Netherlands Research Site Oisterwijk
Netherlands Research Site Roermond
Netherlands Research Site Soerendonk
Netherlands Research Site Steenbergen
Netherlands Research Site Utrecht
Netherlands Research Site Vaassen
Netherlands Research Site Voerendaal
Netherlands Research Site Wamel
Netherlands Research Site Zoetermeer
Netherlands Research Site Zundert
Oman Research Site Muscat
Panama Research Site Calle
Panama Research Site Cocle
Poland Research Site Chorzow
Poland Research Site Elblag
Poland Research Site Gdansk
Poland Research Site Katowice
Poland Research Site Krakow
Poland Research Site Lodz
Poland Research Site Lublin
Poland Research Site Parczew
Poland Research Site Rzeszow
Poland Research Site Zabrze
Poland Research Site Zgierz
Russian Federation Research Site Arkhangelsk
Russian Federation Research Site Barnaul
Russian Federation Research Site Moscow
Russian Federation Research Site Nizhniy Novgorod
Russian Federation Research Site Novosibirsk
Russian Federation Research Site Rostov-on-Don
Russian Federation Research Site Sankt Petersburg
Russian Federation Research Site Saratov
Russian Federation Research Site Sestroretsk
Russian Federation Research Site Stavropol
Russian Federation Research Site Yaroslavl
Saudi Arabia Research Site Abha
Saudi Arabia Research Site Al Jouf
Saudi Arabia Research Site Jeddah
Saudi Arabia Research Site Khamis Mushayt
Saudi Arabia Research Site Riyadh
South Africa Research Site Alberton
South Africa Research Site Cape Town
South Africa Research Site Durban
South Africa Research Site Johannesburg
South Africa Research Site Lenasia
South Africa Research Site Merebank
South Africa Research Site Midstream
South Africa Research Site Moloto
South Africa Research Site Port Elizabeth
South Africa Research Site Pretoria
South Africa Research Site Umkomaas
Spain Research Site Barcelona
Spain Research Site Cadiz
Spain Research Site Elche
Spain Research Site Espinardo
Spain Research Site Madrid
Spain Research Site Mostoles
Spain Research Site Salamanca
Spain Research Site Sanlucar de Barrameda
Spain Research Site Segovia
Spain Research Site Sevilla
Spain Research Site Valencia
Taiwan Research Site Changhua
Taiwan Research Site Kaohsiung
Taiwan Research Site New Taipei City
Taiwan Research Site Taichung
Taiwan Research Site Taichung City
Taiwan Research Site Tainan
Taiwan Research Site Tainan City
Taiwan Research Site Taipei
Tunisia Research Site Gabes
Tunisia Research Site Kairaouane
Tunisia Research Site La Soukra
Tunisia Research Site Mahdia
Tunisia Research Site Mont Fleury
Tunisia Research Site Montfleury
Tunisia Research Site Mutuelleville
Tunisia Research Site Nabeul
Tunisia Research Site Sfax
Tunisia Research Site Sousse
Tunisia Research Site Tunis
Tunisia Research Site Tunis Belvedere
Turkey Research Site Adana
Turkey Research Site Afyonkarahisar
Turkey Research Site Antalya
Turkey Research Site Canakkale
Turkey Research Site Corum
Turkey Research Site Denizli
Turkey Research Site Diyarbakir
Turkey Research Site Duzce
Turkey Research Site Elazig
Turkey Research Site Gaziantep
Turkey Research Site Hatay
Turkey Research Site Istanbul
Turkey Research Site Izmir
Turkey Research Site Karaman
Turkey Research Site Kayseri
Turkey Research Site Samsun
United Arab Emirates Research Site Abu Dhabi
United Arab Emirates Research Site Dubai

Sponsors (1)

Lead Sponsor Collaborator
AstraZeneca

Countries where clinical trial is conducted

Algeria,  Argentina,  Australia,  Austria,  Bahrain,  Brazil,  China,  Colombia,  Costa Rica,  Czechia,  Egypt,  India,  Indonesia,  Italy,  Jordan,  Korea, Republic of,  Kuwait,  Lebanon,  Malaysia,  Mexico,  Netherlands,  Oman,  Panama,  Poland,  Russian Federation,  Saudi Arabia,  South Africa,  Spain,  Taiwan,  Tunisia,  Turkey,  United Arab Emirates, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anti-diabetic treatments prescribed by physicians in a real-world setting. The drugs (or their combinations) prescribed by physicians to patients initiating a 2nd line anti-diabetic treatment in a real-world setting will be described at inclusion and during 3 years follow-up. Up to 3 Years
Secondary Disease control in terms of achieving HbA1c target goals and reducing body weight and blood pressure. Up to 3 years
Secondary Changes in anti-diabetic treatments Up to 3 years
Secondary Disease progression (incidence of microvascular and macrovascular complications). Up to 3 years
Secondary Incidence of hypoglycemic events. Up to 3 years
Secondary Quality of Life, using Patient Reported Outcomes questionnaires. Up to 3 years
Secondary Use of Healthcare resources. Up to 3 years
See also
  Status Clinical Trial Phase
Completed NCT02771093 - An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus Phase 4
Completed NCT02545842 - Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL) Phase 4
Recruiting NCT03436212 - Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump. N/A
Completed NCT03244800 - A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus. Phase 2
Completed NCT03960424 - Diabetes Management Program for Hispanic/Latino N/A
Withdrawn NCT02769091 - A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes Phase 2
Recruiting NCT06065540 - A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor Phase 3
Recruiting NCT05008276 - Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Completed NCT04091373 - A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide Phase 1
Completed NCT03296800 - Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects Phase 1
Recruiting NCT06212778 - Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
Recruiting NCT05979519 - Fresh Carts for Mom's to Improve Food Security and Glucose Management N/A
Recruiting NCT05579314 - XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Terminated NCT03684642 - Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Phase 3
Completed NCT03248401 - Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes Phase 4
Completed NCT03644134 - A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns N/A
Completed NCT05295160 - Fasting-Associated Immune-metabolic Remission of Diabetes N/A
Completed NCT02836873 - Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment Phase 3
Completed NCT02252224 - Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance

External Links